| 摘要 |
<p>Compositions and methods for the treatment of glaucoma and/or ocular hypertension in mammals utilizing prostaglandin E receptor agonists, like rioprostol, sc-46275, enisoprost, misoprostol, nocloprost, 11-deoxy-16, 16-dimethyl-PGE2, 16,16-dimethyl-PGE2 and enprostil, are disclosed.</p> |
